Induced and Inherent Resistance to Alkylating Agents in Human Small-Cell Bronchial Carcinoma Xenografts

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.1984.69
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Silibinin Reverses Drug Resistance in Human Small-Cell Lung Carcinoma Cells

Cancer Letters
Cancer ResearchOncology
2013English

Inherent and Acquired Resistance to Paclitaxel in Hepatocellular Carcinoma: Molecular Events Involved

PLoS ONE
Multidisciplinary
2013English

Relaxin Enhances S100A4 and Promotes Growth of Human Thyroid Carcinoma Cell Xenografts

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2010English

Mismatch Repair Deficiency Is Associated With Resistance to DNA Minor Groove Alkylating Agents

British Journal of Cancer
Cancer ResearchOncology
1999English

Atorvastatin Overcomes Gefitinib Resistance in KRAS Mutant Human Non-Small Cell Lung Carcinoma Cells

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2013English

Resistance to Telomerase Inhibition by Human Squamous Cell Carcinoma Cell Lines

International Journal of Oncology
Cancer ResearchOncology
2011English

Immuno-Pet Evaluation of in Vivo Therapeutic Resistance in Renal Cell Carcinoma Patient-Derived Xenografts

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Cox-2 Inhibition Enhances the Activity of Sunitinib in Human Renal Cell Carcinoma Xenografts

British Journal of Cancer
Cancer ResearchOncology
2013English

Human Lung Small-Cell Carcinoma Contains Bombesin.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy